Financial news in brief: Avecho CBD trial latest; Argent’s milestone delivery – Cannabiz
Pharmaceutical CBD clinical trial development represents important progress in cannabis therapeutics, though patients should maintain realistic expectations about timing and superiority over current protocols. Understanding the distinction between…
Drug Development, Tax Breaks, Future Reimbursement Expected After Medical Marijuana …
Federal policy changes around cannabis drug development tax incentives could reshape medical cannabis access and research funding. Understanding these regulatory shifts helps clinicians prepare for evolving therapeutic landscapes while maintaining focus…
Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis.
Researchers developed HKC54, a selective TRPV2 antagonist that inhibits cancer cell migration in laboratory studies. This TRPV2 antagonist cancer cell migration research represents early-stage drug development that could eventually lead to new…
Trump moves to reschedule marijuana – POLITICO
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyFederal RegulationMedical…
DOJ Expected to Ease Marijuana Controls as Soon as Wed. – YouTube
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyResearchFederal RegulationClinical…
Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis.
TRPV2 is the least studied member of the vanilloid TRP subfamily despite its emerging relevance in cancer metastasis, pain, and inflammation. Although severa...
Chinese researchers develop cannabis-based molecule with strong pain relief, fewer side effects
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Pain ManagementSynthetic CannabinoidsDrug…
CBC–RIS partnership signals AI-led transformation for healthcare and pharma: Experts
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Artificial IntelligenceClinical Decision…
Two compounds found in cannabis plant reverse liver disease damage, study suggests
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic HepatologyPreclinical…
Forge Genetics announces licensing deal to explore Forge Editing in pharmaceutical uses
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic BiotechnologyDrug DevelopmentGene…